Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience [0.03%]
Niklas Ebert,Florian Rosar,Caroline Burgard et al.
Niklas Ebert et al.
Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting [0.03%]
Emirhan Harbi,Gokce Belge Bilgin,Louise Emmett et al.
Emirhan Harbi et al.
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer [0.03%]
Alina Toni Küper,Sofia Carrilho Vaz,Kim Magaly Pabst et al.
Alina Toni Küper et al.
Background: Fibroblast activation protein (FAP)-targeted tracers have emerged as promising agents for breast cancer imaging, with recent studies demonstrating PET performance comparable to or surpassing, that of [18F]FDG....
Optimal acquisition time of [68Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocol [0.03%]
[68Ga]Ga-PentixaFor PET/CT初诊多发性骨髓瘤分期的 optimal 获取时间：PentiMyelo方案的探索性研究
Chloé François,Thomas Carlier,Cyrille Touzeau et al.
Chloé François et al.
A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal [18F] FDG PET imaging [0.03%]
一种稳健且通用的深度学习模型 用于小动物正电子发射断层成像中动脉输入函数的预测
Christian Salomonsen,Luigi T Luppino,Fredrik Aspheim et al.
Christian Salomonsen et al.
EJNMMI research: a vision for the next era of nuclear medicine [0.03%]
分子影像和核医学研究：展望下一个时代的影响学和核医学研究期刊
Marcus Hacker
Marcus Hacker
Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancer [0.03%]
interim ¹¹C-choline PET/CT预测阳性对镭-223治疗转移性去势抵抗性前列腺癌的反应价值
Eman E Ahmed,Jack R Andrews,Mohamed E Ahmed et al.
Eman E Ahmed et al.
Assessment of striatal and extrastriatal [18F]fluoroDOPA uptake by a Silicon Photomultiplier PET camera in Parkinson's disease [0.03%]
帕金森病中[18F]氟多巴在黑质外区域的摄取分布及硅光电倍增管PET显像评估
Jacques Darcourt,Pierre-Malick Koulibaly,Aurélie Schiazza et al.
Jacques Darcourt et al.
Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein [0.03%]
针对成纤维活化蛋白的预临床治疗诊断研究：结合[177Lu]Lu-FAPI-2286和培唑帕尼在肉瘤模型中的抗肿瘤活性
Jin-Ren Tseng,Cheng-Lung Hsu,Hsin-Hua Hsieh et al.
Jin-Ren Tseng et al.
Harmonized quantitative bone SPECT/CT parameters for risk assessment of medication-related osteonecrosis of the jaw: multicenter study [0.03%]
多中心研究建立的药物相关性颌骨坏死风险评估的规范化定量骨SPECT/CT参数
Kazuhiro Kitajima,Yu Iwabuchi,Yoshitaka Inui et al.
Kazuhiro Kitajima et al.